Edwards Lifesciences Corporation ( NYSE: EW) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Mark Wilterding - SVP, Global Finance Bernard Zovighian - CEO Scott Ullem - CFO Daveen Chopra - ...

The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the ...

Edwards SAPIEN M3 mitral valve replacement system receives CE Mark for transcatheter treatment: Irvine, California Wednesday, ...

Edwards Lifesciences announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system.

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

Edwards Lifesciences has received Europe’s CE mark for its transcatheter mitral valve replacement system, Sapien M3, the ...

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

The Irvine-based medical device maker today announced that it received CE mark approval for its Sapien M3 mitral replacement ...

Edwards Lifesciences (EW) announced the company’s Sapien M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received ...

The Cardiac Dimensions Carillon Mitral Contour System is a minimally invasive treatment for mitral valve regurgitation that would not be possible without nitinol and advanced catheter technology.

The vibrations were felt by residents indoors as if a truck was passing by. The BMKG team noted a subsequent earthquake with a magnitude of M3.9 at 02:56 WIB, half an hour after the initial incident. ...